Early buyers will receive 10% customization on this report.
Factors such as increasing research and development expenditure of life science and clinical research industries, rising number of clinical trials, increasing number of new product launches, and increasing customer base owing to the rising adoption of CTMS solutions are driving the growth of the global CTMS market.
On the other hand, factors such as lack of skilled professionals to operate advanced CTMS and budget constraints of small- and medium-sized pharmaceutical and biotechnology companies and small CROs are restricting the growth of the global CTMS market.
This report covers four major end users, namely, pharmaceutical and biopharmaceutical companies, contract research organizations, medical device companies, and others.
The pharmaceutical and biopharmaceutical companies segment is expected to account for the largest share of the CTMS market in 2016. The large share of this segment can be attributed to the increasing adoption of CTMS software during drug clinical trials by pharmaceutical and biopharmaceutical companies. The contract research organizations segment is estimated to witness the highest growth during the forecast period, primarily due to the rising trend of clinical trial outsourcing to CROs.
On the basis of delivery mode, the global CTMS market is segmented into web-based (on-demand), licensed enterprise (on-premise), and cloud-based (SaaS) segments.
The cloud-based (SaaS) segment is estimated to witness the highest growth during the forecast period, primarily due to the rising adoption of cloud-based solutions in medical research studies owing to various benefits offered by them such as low cost, high security, privacy, and easy accessibility from any device.
On the basis of component, the CTMS market is segmented into software and services. The software segment is expected to account for the largest share of the global CTMS market in 2016, and is also expected to grow at the highest CAGR during the forecast period.
This high growth is mainly attributed to the fierce competition in the pharmaceutical industry to introduce cost-effective novel drugs in the market, increased adoption of CTMS due to advantages provided by the same among various end users, and increasing number of clinical trials.
The CTMS market is further segmented into enterprise CTMS and site CTMS on the basis of type. The enterprise CTMS segment is expected to command the largest share of the global CTMS market in 2016, and is expected to grow at the highest CAGR in the forecast period. This is attributed to the widespread adoption of enterprise CTMS by majority of the end users.
North America commands the largest share of the global CTMS market in 2016, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR from 2016 to 2021. Factors such as increase in outsourcing of clinical trials, availability of large and diverse patient population, presence of less stringent regulatory guidelines as compared to developed nations, and comparatively less cost of conducting clinical trials in APAC countries are driving growth of the market.
Oracle Corporation (U.S.), Medidata Solutions, Inc. (U.S.), and PAREXEL International Corporation (U.S.) are the major players in the global CTMS market.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
